Presentation is loading. Please wait.

Presentation is loading. Please wait.

Progress Against Leukemia. 1970–1979 Progress Against Leukemia 1970–1979 1974: FDA approves doxorubicin.

Published byDylan McGregor Modified over 11 years ago

Similar presentations

Presentation on theme: "Progress Against Leukemia. 1970–1979 Progress Against Leukemia 1970–1979 1974: FDA approves doxorubicin."— Presentation transcript:

1 Progress Against Leukemia

2 1970–1979

3 Progress Against Leukemia 1970–1979 1974: FDA approves doxorubicin

4 Progress Against Leukemia 1970–1979 1975: Era of bone marrow transplantation begins – extending lives of many patients with leukemia and lymphoma

5 Progress Against Leukemia 1970–1979 1977: Chlorambucil induces remissions for chronic lymphocytic leukemia

6 Progress Against Leukemia 1980–1989

7 Progress Against Leukemia 1980–1989 1982: Daunorubicin proven superior to doxorubicin for AML

8 Progress Against Leukemia 1980–1989 1986: National bone marrow transplantation registry is established

9 Progress Against Leukemia 1980–1989 Late 1980s: Benzene established to cause cancer

10 Progress Against Leukemia 1990–1999

11 Progress Against Leukemia 1990–1999 1995: Lymphocyte transfusions re-induce leukemia remissions 1995: Approval of tretinoin leads to 95 percent cure rate for rare leukemia

12 Progress Against Leukemia 2000–Present

13 Progress Against Leukemia 2000–Present 2000: Fludarabine works faster, better for patients with CLL

14 Progress Against Leukemia 2000–Present 2001: New targeted therapy – imatinib – proven effective against chronic myelogenous leukemia

15 Progress Against Leukemia 2000–Present 2004, 2006: Epigenetic drugs approved to prevent cancer in patients with myelodysplastic syndromes

16 Progress Against Leukemia 2000–Present 2005: Drug approved to reduce oral sores caused by cancer treatment

17 Progress Against Leukemia 2000–Present 2006: New drug helps CML patients who become resistant to imatinib

18 Progress Against Leukemia 2000–Present 2007: Addition of an arsenic compound found to improve survival for rare form of leukemia 2007: Study supports expanded use of dasatinib for CML 2007: Bendamustine is effective against chronic lymphocytic leukemia (CLL)

19 Progress Against Leukemia 2000–Present 2009: Genome of acute myelogenous leukemia is sequenced

20 Progress Against Leukemia 2000–Present 2010: Tyrosine kinase inhibitors provide additional options for CML 2011: Adding rituximab extends survival for chronic lymphocytic leukemia

21 Progress Against Leukemia Five-Year Survival Source: National Cancer Institute

22 Progress Against Leukemia Mortality Source: National Cancer Institute

23 Progress Against Leukemia New Cases Source: National Cancer Institute

24 Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and research new cures

Download ppt "Progress Against Leukemia. 1970–1979 Progress Against Leukemia 1970–1979 1974: FDA approves doxorubicin."

Similar presentations

Major Cancer Milestones

Major Cancer Milestones
Progress Against Breast Cancer

Progress Against Breast Cancer
Progress Against Prostate Cancer. 1970–1979 Progress Against Prostate Cancer 1970–1979 Early 1970s: Radioactive ''seeds'' proven effective for prostate.

Progress Against Prostate Cancer. 1970–1979 Progress Against Prostate Cancer 1970–1979 Early 1970s: Radioactive ''seeds'' proven effective for prostate.
Progress Against Lung Cancer. 1970–1979 Progress Against Lung Cancer 1970–1979 Mid-1970s: Chemotherapy combinations prove effective in small cell lung.

Progress Against Lung Cancer. 1970–1979 Progress Against Lung Cancer 1970–1979 Mid-1970s: Chemotherapy combinations prove effective in small cell lung.
Progress Against Stomach Cancer. 1980–1989 Progress Against Stomach Cancer 1980–1989 1980: Combination chemotherapy improves outcomes for advanced stomach.

Progress Against Stomach Cancer. 1980–1989 Progress Against Stomach Cancer 1980– : Combination chemotherapy improves outcomes for advanced stomach.
Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970–1979 1974: FDA approves doxorubicin, a vital part of combination chemotherapy.

Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970– : FDA approves doxorubicin, a vital part of combination chemotherapy.
Progress Against Bladder Cancer. Pre-1970 Progress Against Bladder Cancer Pre-1970 1879: Tool offers view inside bladder for first time.

Progress Against Bladder Cancer. Pre-1970 Progress Against Bladder Cancer Pre : Tool offers view inside bladder for first time.
Progress Against Ovarian Cancer. 1970–1979 Progress Against Ovarian Cancer 1970–1979 1978: First effective combination chemotherapy regimen for ovarian.

Progress Against Ovarian Cancer. 1970–1979 Progress Against Ovarian Cancer 1970– : First effective combination chemotherapy regimen for ovarian.
Progress Against Testicular Cancer. 1970–1979 Progress Against Testicular Cancer 1970–1979 1970: Two new drugs produce first complete remissions in advanced.

Progress Against Testicular Cancer. 1970–1979 Progress Against Testicular Cancer 1970– : Two new drugs produce first complete remissions in advanced.
Progress Against Cervical Cancer. 1980–1989 Progress Against Cervical Cancer 1980–1989 1983–1984: HPV virus is discovered to cause cervical cancer.

Progress Against Cervical Cancer. 1980–1989 Progress Against Cervical Cancer 1980– –1984: HPV virus is discovered to cause cervical cancer.
Progress Against Head and Neck Cancer. 1970–1979.

Progress Against Head and Neck Cancer. 1970–1979.
Progress Against Melanoma. 1970–1979 Progress Against Melanoma 1970–1979 1978: Hereditary syndrome linked to increased melanoma risk.

Progress Against Melanoma. 1970–1979 Progress Against Melanoma 1970– : Hereditary syndrome linked to increased melanoma risk.
Progress Against Kidney Cancer. 1970–1979 Progress Against Kidney Cancer 1970–1979 1977: Removing just part of the cancerous kidney is proven safe and.

Progress Against Kidney Cancer. 1970–1979 Progress Against Kidney Cancer 1970– : Removing just part of the cancerous kidney is proven safe and.
Progress Against Pancreatic Cancer. 1970–1979 Progress Against Pancreatic Cancer 1970–1979 1970s: Tobacco use found to cause pancreatic cancer.

Progress Against Pancreatic Cancer. 1970–1979 Progress Against Pancreatic Cancer 1970– s: Tobacco use found to cause pancreatic cancer.
Progress Against Liver Cancer. 1970–1979 Progress Against Liver Cancer 1970–1979 1975: First study finds chemotherapy effective for liver cancer.

Progress Against Liver Cancer. 1970–1979 Progress Against Liver Cancer 1970– : First study finds chemotherapy effective for liver cancer.
Presenter Name(s) 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Issue date National Student.

Presenter Name(s) Issue date National Student.
19811983 1982 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 First cases of AIDS identified.

First cases of AIDS identified.
Through the years… JUNIATA COLLEGE FIELD HOCKEY. SeasonCoachRecord 1973Unknown2-3-1 1974Jo Reilly2-5 1975Alexa Fultz3-8 1976Alexa Fultz5-5 1977Nancy Harden-Latimore4-4-1.

Through the years… JUNIATA COLLEGE FIELD HOCKEY. SeasonCoachRecord 1973Unknown Jo Reilly Alexa Fultz Alexa Fultz Nancy Harden-Latimore4-4-1.
From Delft into Almere Prof.dr.ir.Taeke M. de Jong.

From Delft into Almere Prof.dr.ir.Taeke M. de Jong.
Reduced Incidence of ESRD among 60 to 80–year-olds in Denmark Heaf JG 1, Wehberg S 2, Engberg H 2 Danish Nephrology Registry 1 Herlev Hospital, University.

Reduced Incidence of ESRD among 60 to 80–year-olds in Denmark Heaf JG 1, Wehberg S 2, Engberg H 2 Danish Nephrology Registry 1 Herlev Hospital, University.

Similar presentations

Ads by Google